Nonpeptide αvβ3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimetics

Potent, novel 7-oxo αvβ3 antagonists have been prepared. These antagonists offer decreased plasma protein binding and excellent pharmacokinetic profiles.